Article citationsMore>>

Sud, S., O’Callaghan, C., Jonker, C., Karapetis, C., Price, T., Tebbutt, N., et al. (2018) Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response. Current Oncology, 25, 516-526.
https://doi.org/10.3747/co.25.4069

has been cited by the following article:

• TITLE: Study on the Correlation between Metabolic Syndrome and Colorectal

  AUTHORS: Jin Wei, Ping Lu

  KEYWORDS: Metabolic Syndrome, Obesity, Hypertension, Lipid Disorders, Colorectal Adenoma, Colorectal Cancer

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.7, July 4, 2024

  ABSTRACT: Metabolic syndrome has been widely recognized in various studies as being intricately linked to the initiation and progression of colorectal adenoma. The potential pathways through which metabolic syndrome influences colorectal adenoma encompass chronic inflammation, insulin resistance, oxidative stress, and dysbiosis of the intestinal flora. This review aims to consolidate the understanding of the association between metabolic syndrome and colorectal adenoma, elucidating the interconnected mechanisms between different metabolic syndrome-related disorders and colorectal adenoma. By shedding light on these connections, this review offers valuable insights for the preventive strategies targeting colorectal adenoma.